Anebulo Pharmaceuticals, Inc.·4

Oct 4, 4:13 PM ET

Lawler Joseph F. 4

4 · Anebulo Pharmaceuticals, Inc. · Filed Oct 4, 2022

Insider Transaction Report

Form 4
Period: 2022-04-21
Lawler Joseph F.
Director10% Owner
Transactions
  • Award

    Stock Option (right to buy)

    2022-04-21+30,42530,425 total
    Exercise: $6.00Exp: 2027-02-28Common Stock (30,425 underlying)
Holdings
  • Common Stock

    (indirect: By CAL GRAT 2022-1)
    5,000,000
  • Common Stock

    2,000,000
  • Common Stock

    (indirect: By JFL GRAT 2022-1)
    5,000,000
Footnotes (3)
  • [F1]Excludes 10,000,000 shares previously owned directly by the reporting person which were contributed to grantor retained annuity trusts on September 26, 2022, and which shares are now reflected as owned indirectly in this Form 4.
  • [F2]The reporting person is the sole trustee, and the reporting person and his spouse are the sole beneficiaries, of this grantor retained annuity trust.
  • [F3]25% of the option vests on March 1, 2023. Thereafter, 1/48 of the option vests on a monthly basis over 36 months until the option becomes fully vested.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION